Table 2.
Group (n = 8) | TNF-α (pg/ml) | IL-18 (pg/ml) week 6 | |
---|---|---|---|
week 2 | week 6 | ||
Healthy | 22.71 ± 1.79 | 23.87 ± 5.11 | 30.28 ± 1.76 |
Arthritic | 43.15 ± 1.57**** | 39.80 ± 4.38**** | 38.03 ± 3.35** |
BQ-high dose | 43.35 ± 1.84**** | 34.04 ± 5.22** | 33.69 ± 4.36 |
BQ-moderate dose | 42.68 ± 2.30**** | 31.87 ± 2.88*, ∆ | 32.37 ± 4.20∆ |
MTX | 43.28 ± 2.29**** | 33.84 ± 4.39** | 32.32 ± 3.61∆ |
Data are presented as mean ± SD
BQ Bi-Qi capsule, MTX methotrexate
Significant effect of treatment compared to control, **P < 0.01, ****P < 0.0001; compared to arthritic group, ∆P < 0.05